Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

BIOsens

Financiado

BIOsens cutting edge portable device for precise and rapid analysis of crops

Every year, companies involved in agriculture businesses experience significant financial losses because of mycotoxins – invisible and dangerous for human health foodborne toxins, which contaminates 25% of the global supply. Farme... ver más

30/09/2019

BIOsens

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

LLC BIOSENS UKRAINE No se ha especificado una descripción o un objeto social para esta compañía.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-09-30

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 6 años

0% 100%

2 Participantes

BIOsens

50.00K€ | Lider

NETPOINT SOLUTIONS

363.73K€ | Participante

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 5 meses Fecha Inicio: 2019-04-17
Fecha Fin: 2019-09-30

Líder del proyecto

LLC BIOSENS UKRAINE

Presupuesto del proyecto 71K€

Descripción del proyecto Every year, companies involved in agriculture businesses experience significant financial losses because of mycotoxins – invisible and dangerous for human health foodborne toxins, which contaminates 25% of the global supply. Farmers, grain elevator owners, and food processing companies suffer the most from this issue and crave for the solution that will allow them easily, swiftly and accurately detect mycotoxins on-site. Timely detection of mycotoxins will prevent them from unsuccessful trade or border rejections, and will lead to revenue increase. BIOsens provides cutting-edge solution that successfully tackles the problem of agriculture companies by creating an easy-to-use portable device for mycotoxin analysis. The mycotoxins testing market is expected to grow to USD 1.75 billion in 2023, and BIOsens is the first solution on the market which combines the accuracy of laboratory testing and the speed of onsite devices. BIOsens team comprises of experts in Biochemistry, Biotechnology, IT and Business which ensure the high quality of the developed solution and successful market entry. According to Financial Times, company’s CEO Andrii Karpiuk is one of 100 eastern Europe’s emerging technology stars and the team has already won numerous start-up competitions, including Intercontinental Startup Battle in San-Francisco. BIOsens aims for global commercialization to ensure that people all over the world consume safe food. SME Instrument Phase 1 funding will enable the company to validate customer needs, conduct thorough analysis of target markets and validate priority countries for market entry, research regulatory requirement and develop an IRP strategy, validate business model and as a result create an elaborated business plan for the successful commercialization of the device.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores